Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA
Status:
Completed
Trial end date:
2016-06-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the efficacy and safety of 800 mg Chondroitin 4&6
sulfate (Condrosulf) vs placebo once a day for 6 months in the symptomatic treatment of knee
osteoarthritis. A third group, Celecoxib 200 mg (Celebrex) once a day, will be used as active
comparator.